{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:50:08Z","timestamp":1793137808977,"version":"4.5.0"},"reference-count":311,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI164968"],"award-info":[{"award-number":["AI164968"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK084195"],"award-info":[{"award-number":["DK084195"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR083247"],"award-info":[{"award-number":["AR083247"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305,981\/2023\\u20134"],"award-info":[{"award-number":["305,981\/2023\\u20134"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.autrev.2025.103756","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T08:51:08Z","timestamp":1737622268000},"page":"103756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Amanda Carolina Miranda","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunes","family":"DPF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Rog\u00e9rio","family":"J\u00falio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Marchi-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Martins","family":"De Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"de Oliveira Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Rodrigues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tais Nitsch","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marcos","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Rolim Muro","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Marcondes Cavalcante","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Niewold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Appenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103756_bb0005","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0010","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0020","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American College of Rheumatology Classification Criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0025","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2025.103756_bb0035","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-021-00710-2","article-title":"Differentiating between UCTD and early-stage SLE: from definitions to clinical approach","volume":"18","author":"Sciascia","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100129","article-title":"Autoimmune rheumatic diseases: one or many diseases?","volume":"4","author":"Moutsopoulos","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.autrev.2025.103756_bb0050","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ajhg.2014.10.004","article-title":"Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases","volume":"95","author":"Gusev","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2025.103756_bb0055","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103756_bb0060","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic localization of common disease-associated variation in regulatory DNA","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.autrev.2025.103756_bb0065","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.3933","article-title":"Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases","volume":"21","author":"Li","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0070","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41588-024-01732-8","article-title":"Genetic mapping across autoimmune diseases reveals shared associations and mechanisms","volume":"56","author":"Lincoln","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2025.103756_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108953","article-title":"Systemic lupus erythematosus as a genetic disease","volume":"236","author":"Harley","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0080","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/1744666X.2023.2240959","article-title":"A review of genetic risk in systemic lupus erythematosus","volume":"19","author":"Guga","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/O10-112","article-title":"MeCP2: structure and function","volume":"89","author":"Adkins","year":"2011","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.autrev.2025.103756_bb0090","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/eji.201142307","article-title":"Silencing of the Il2 gene transcription is regulated by epigenetic changes in anergic T cells","volume":"42","author":"Bandyopadhyay","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0095","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.10833","article-title":"Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling","volume":"48","author":"Deng","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fgene.2014.00418","article-title":"Dysregulation of antiviral helicase pathways in systemic lupus erythematosus","volume":"5","author":"Oliveira","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.autrev.2025.103756_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2302\/kjm.60.10","article-title":"Epigenetics and autoimmunity, with special emphasis on methylation","volume":"60","author":"Renaudineau","year":"2011","journal-title":"Keio J Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0110","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4161\/rna.20090","article-title":"RNA helicases in infection and disease","volume":"9","author":"Steimer","year":"2012","journal-title":"RNA Biol"},{"key":"10.1016\/j.autrev.2025.103756_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biocel.2015.05.022","article-title":"Epigenetic dynamics in immunity and autoimmunity","volume":"67","author":"Zhao","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.autrev.2025.103756_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040587","article-title":"Peripheral neuropathy in systemic autoimmune rheumatic diseases-diagnosis and treatment","volume":"16","author":"De Souza","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.autrev.2025.103756_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ph17081044","article-title":"Central nervous system involvement in systemic autoimmune rheumatic diseases-diagnosis and treatment","volume":"17","author":"Juncker","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.autrev.2025.103756_bb0130","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.autrev.2015.07.015","article-title":"Neuropsychiatric manifestations in rheumatoid arthritis","volume":"14","author":"Joaquim","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/1744666X.2019.1564040","article-title":"Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus","volume":"15","author":"de Amorim","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0140","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/1744666X.2022.2117159","article-title":"Neuropsychiatric manifestations in primary Sjogren syndrome","volume":"18","author":"Appenzeller","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.berh.2019.01.020","article-title":"Mimickers of neuropsychiatric manifestations in systemic lupus erythematosus","volume":"32","author":"de Amorim","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fmed.2018.00138","article-title":"Definition of NPSLE: does the ACR nomenclature still hold?","volume":"5","author":"Vivaldo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2025.103756_bb0160","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","article-title":"The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus","volume":"57","author":"Ainiala","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103756_bb0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WCO.0000000000000822","article-title":"Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus","volume":"33","author":"Mackay","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2016.04.005","article-title":"Autoimmunity, neuroinflammation, pathogen load: a decisive crosstalk in neuropsychiatric SLE","volume":"74","author":"Jeltsch-David","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103756_bb0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103756_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084605","article-title":"Neurological involvement in primary Sjogren syndrome: a focus on central nervous system","volume":"9","author":"Morreale","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103756_bb0185","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.31.11.1391","article-title":"Sjogren syndrome: central nervous system manifestations","volume":"31","author":"Alexander","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103756_bb0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1590\/0004-282x20180015","article-title":"Definition and diagnosis of small fiber neuropathy: consensus from the peripheral neuropathy scientific Department of the Brazilian Academy of neurology","volume":"76","author":"Gondim","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.autrev.2025.103756_bb0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12906-021-03401-3","article-title":"Headache and migraine clinical practice guidelines: a systematic review and assessment of complementary and alternative medicine recommendations","volume":"21","author":"Ng","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.autrev.2025.103756_bb0200","article-title":"Evidence-based guidelines for Sj\u00f6gren\u2019s disease peripheral nervous system manifestations (S38. 004)","author":"Sarka","year":"2024","journal-title":"Neurology. AAN Enterprises"},{"key":"10.1016\/j.autrev.2025.103756_bb0205","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/annrheumdis-2019-216150","article-title":"Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach","volume":"79","author":"Hanly","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0215","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0961203319828499","article-title":"Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome","volume":"28","author":"Bortoluzzi","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semarthrit.2020.09.018","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus","volume":"51","author":"Julio","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030355","article-title":"Microstructural changes in the Corpus callosum in systemic lupus erythematous","volume":"12","author":"Julio","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2025.103756_bb0230","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3899\/jrheum.081133","article-title":"Prospective study of neuropsychiatric events in systemic lupus erythematosus","volume":"36","author":"Hanly","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0235","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.csbj.2022.01.002","article-title":"Addressing the clinical unmet needs in primary Sjogren\u2019s syndrome through the sharing, harmonization and federated analysis of 21 European cohorts","volume":"20","author":"Pezoulas","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.autrev.2025.103756_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13145","article-title":"Disease mechanisms in Sjogren\u2019s syndrome: what do we know?","volume":"95","author":"Jonsson","year":"2022","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40674-017-0076-9","article-title":"Neurological complications of Sjogren\u2019s syndrome: diagnosis and management","volume":"3","author":"McCoy","year":"2017","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0250","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2025.103756_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1665","article-title":"Neuro-Sjogren: uncommon or underestimated problem?","volume":"10","author":"Jaskolska","year":"2020","journal-title":"Brain Behav"},{"key":"10.1016\/j.autrev.2025.103756_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.615656","article-title":"Peripheral nervous system involvement in Sjogren\u2019s syndrome: analysis of a cohort from the Italian research group on Sjogren\u2019s syndrome","volume":"12","author":"Cafaro","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl. 118","key":"10.1016\/j.autrev.2025.103756_bb0270","first-page":"192","article-title":"The kaleidoscope of neurological manifestations in primary Sjogren\u2019s syndrome","volume":"37","author":"Alunno","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0275","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004150170135","article-title":"Neurological complications of primary Sjogren's syndrome","volume":"248","author":"Lafitte","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb0280","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1016\/j.lpm.2012.06.002","article-title":"Central and peripheral neurological complications of primary Sjogren\u2019s syndrome","volume":"41","author":"Fauchais","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0285","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0034-1390391","article-title":"Neurologic complications of systemic lupus erythematosus, sjogren syndrome, and rheumatoid arthritis","volume":"34","author":"Bhattacharyya","year":"2014","journal-title":"Semin Neurol"},{"issue":"273\u2013298","key":"10.1016\/j.autrev.2025.103756_bb0290","first-page":"vi","article-title":"Neuropsychiatric lupus","volume":"31","author":"Hanly","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2025.103756_bb0295","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0300","first-page":"732","article-title":"Brain pathology in systemic lupus erythematosus","volume":"19","author":"Hanly","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0305","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/art.27458","article-title":"The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus","volume":"62","author":"Brooks","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0310","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2741\/1273","article-title":"Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage","volume":"9","author":"Zaccagni","year":"2004","journal-title":"Front Biosci"},{"key":"10.1016\/j.autrev.2025.103756_bb0315","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0609.1994.tb00100.x","article-title":"Circulating intercellular adhesion molecule-1 and soluble interleukin 2-receptor in patients with systemic lupus erythematosus","volume":"52","author":"Matsuda","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.autrev.2025.103756_bb0320","first-page":"5","article-title":"Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus","volume":"12","author":"Sfikakis","year":"1994","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0325","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.1994.tb06107.x","article-title":"Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study","volume":"97","author":"Spronk","year":"1994","journal-title":"Clinical & Experimental Immunology"},{"key":"10.1016\/j.autrev.2025.103756_bb0330","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1042\/BST20140319","article-title":"The blood-brain barrier endothelium: a target for pro-inflammatory cytokines","volume":"43","author":"Rochfort","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.autrev.2025.103756_bb0335","first-page":"645","article-title":"Immunoperoxidase staining of the choroid plexus in systemic lupus erythematosus","volume":"7","author":"Boyer","year":"1980","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0340","doi-asserted-by":"crossref","first-page":"1326751","DOI":"10.3389\/fimmu.2023.1326751","article-title":"Serum S100A8\/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment","volume":"14","author":"Munoz-Grajales","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0345","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/acr2.11217","article-title":"Role of serum IL-6 in neuropsychiatric systemic lupus erythematosus","volume":"3","author":"Hirohata","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.998328","article-title":"Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: a review","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.autrev.2025.103756_bb0355","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/art.1780330506","article-title":"Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system invol vement","volume":"33","author":"Hirohata","year":"1990","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"key":"10.1016\/j.autrev.2025.103756_bb0360","article-title":"Longitudinal comparison of IL-6, IL-10, and IL-12 cytokine profiles in adult and childhood-onset systemic lupus erythematosus","volume":"5","author":"de Oliveira Peli\u00e7ari","year":"2022","journal-title":"Journal of Translational Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103756_bb0365","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/1529-0131(199912)42:12<2729::AID-ANR35>3.0.CO;2-I","article-title":"Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus","volume":"42","author":"Hirohata","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0370","first-page":"2010","article-title":"Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin","volume":"34","author":"Katsumata","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0375","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/03009749409103028","article-title":"Cerebrospinal fluid lnterleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections","volume":"23","author":"Tsai","year":"1994","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0380","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10067-009-1226-8","article-title":"Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study","volume":"28","author":"Hirohata","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0385","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/ard.60.4.372","article-title":"Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus","volume":"60","author":"Svenungsson","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0390","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0395","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/rheumatology\/36.2.190","article-title":"Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus","volume":"36","author":"Gilad","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0400","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1191\/0961203303lu472sr","article-title":"The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles","volume":"12","author":"Jonsen","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb0405","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2484","article-title":"Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms","volume":"10","author":"George-Chandy","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2025.103756_bb0410","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12974-015-0471-9","article-title":"Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus","volume":"13","author":"Postal","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2025.103756_bb0415","series-title":"Retraction note: Microglia-dependent synapse loss in type I interferon-mediated lupus","author":"Bialas","year":"2020"},{"key":"10.1016\/j.autrev.2025.103756_bb0420","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4049\/jimmunol.182.2.1192","article-title":"Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"182","author":"Santer","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0425","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12974-020-02003-z","article-title":"Microglial responses to peripheral type 1 interferon","volume":"17","author":"Aw","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2025.103756_bb0430","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/rheumatology\/keab530","article-title":"Axonal dysfunction is associated with interferon-gamma levels in childhood-onset systemic lupus erythematosus: a multivoxel magnetic resonance spectroscopy study","volume":"61","author":"Frittoli","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103756_bb0435","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000479319","article-title":"Interferon-gamma is associated with cerebral atrophy in systemic lupus erythematosus","volume":"24","author":"Postal","year":"2017","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.autrev.2025.103756_bb0440","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2005.041640","article-title":"Raised monocyte chemotactic protein-1 (MCP-1)\/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"65","author":"Iikuni","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0445","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/art.20598","article-title":"Interferon-inducible protein 10\/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus","volume":"50","author":"Okamoto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0450","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2741\/2864","article-title":"Chemokines in systemic lupus erythematosus involving the central nervous system","volume":"13","author":"Kasama","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.autrev.2025.103756_bb0455","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10067-007-0722-y","article-title":"Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus","volume":"27","author":"Yang","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0460","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/0961203317691374","article-title":"S100beta is associated with cognitive impairment in childhood-onset systemic lupus erythematosus patients","volume":"26","author":"Lapa","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb0465","doi-asserted-by":"crossref","DOI":"10.5387\/fms.2020-02","article-title":"Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers","volume":"66","author":"Sato","year":"2020","journal-title":"Fukushima J Med Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb0470","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb0475","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198707303170503","article-title":"Association between lupus psychosis and anti-ribosomal P protein antibodies","volume":"317","author":"Bonfa","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0480","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1191\/0961203305lu2150rr","article-title":"Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?","volume":"14","author":"Ebert","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb0485","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.59.2.99","article-title":"The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease","volume":"59","author":"Tzioufas","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0490","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00109-003-0423-1","article-title":"Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins","volume":"81","author":"Mahler","year":"2003","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.autrev.2025.103756_bb0495","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.23218","article-title":"Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study","volume":"58","author":"Hanly","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0500","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0505","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0510","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/0961203312451201","article-title":"Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus","volume":"21","author":"Aldar","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb0515","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.reuma.2009.01.006","article-title":"Deciphering the association of anti P ribosomal antibodies and neuropsychiatric affection in systemic lupus erythematosus","volume":"6","author":"de Carvalho","year":"2010","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.autrev.2025.103756_bb0520","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/s10165-010-0354-y","article-title":"Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes","volume":"21","author":"Nagai","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0525","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cyto.2011.08.026","article-title":"The role of tumor necrosis factor-alpha (TNF-alpha) in the pathogenesis of systemic lupus erythematosus","volume":"56","author":"Postal","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2025.103756_bb0530","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaut.2008.09.002","article-title":"Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression)","volume":"31","author":"Katzav","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103756_bb0535","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.autrev.2018.02.002","article-title":"Olfactory function in systemic lupus erythematosus and systemic sclerosis. A longitudinal study and review of the literature","volume":"17","author":"Bombini","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb0540","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s00415-014-7406-8","article-title":"Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review","volume":"261","author":"Sciascia","year":"2014","journal-title":"J Neurol"},{"issue":"187\u2013201","key":"10.1016\/j.autrev.2025.103756_bb0545","first-page":"x","article-title":"Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus","volume":"36","author":"Aranow","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2025.103756_bb0550","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0165-6147(00)01642-4","article-title":"Glutamate signalling in non-neuronal tissues","volume":"22","author":"Skerry","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb0555","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0560","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/art.22031","article-title":"Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus","volume":"54","author":"Lapteva","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0565","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00415-011-6232-5","article-title":"Systemic lupus erythematosus, the brain, and anti-NR2 antibodies","volume":"259","author":"Lauvsnes","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb0570","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0002-9343(81)90756-7","article-title":"Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus","volume":"70","author":"Bluestein","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0575","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/s10165-009-0198-5","article-title":"Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers","volume":"19","author":"Efthimiou","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0580","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000559","article-title":"Quinolinic acid, a kynurenine\/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus","volume":"8","author":"Anderson","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0585","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.37893","article-title":"Brief report: attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus","volume":"65","author":"Garcia","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0590","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/acr2.11668","article-title":"Redox pathogenesis in rheumatic diseases","volume":"6","author":"Laniak","year":"2024","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0595","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.autrev.2025.103756_bb0600","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1038\/s41467-024-46441-2","article-title":"Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation","volume":"15","author":"Huang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103756_bb0605","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12868-023-00839-8","article-title":"Cognitive dysfunction in systemic lupus erythematosus is associated with disease activity and oxidative stress: a comparative study with rheumatoid arthritis for identifying biomarkers","volume":"24","author":"de Sousa","year":"2023","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.autrev.2025.103756_bb0610","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.3390\/ijms20205183","article-title":"Cross-talk between mitochondrial dysfunction-provoked oxidative stress and aberrant noncoding RNA expression in the pathogenesis and pathophysiology of SLE","volume":"20","author":"Tsai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb0615","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.freeradbiomed.2020.12.006","article-title":"Oxidative stress-induced aberrant lipid metabolism is an important causal factor for dysfunction of immunocytes from patients with systemic lupus erythematosus","volume":"163","author":"Hu","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0620","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/137231","article-title":"The association among antioxidant enzymes, autoantibodies, and disease severity score in systemic lupus erythematosus: comparison of neuropsychiatric and nonneuropsychiatric groups","volume":"2014","author":"Su","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2025.103756_bb0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125109","article-title":"Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus","volume":"10","author":"Lood","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103756_bb0630","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000254","article-title":"Kynurenine pathway is altered in patients with SLE and associated with severe fatigue","volume":"5","author":"Akesson","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0635","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.autrev.2025.103756_bb0640","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0645","first-page":"850","article-title":"Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations","volume":"23","author":"Vogelgesang","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0650","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2025.103756_bb0655","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1136\/ard.2009.114157","article-title":"TREX1 gene variant in neuropsychiatric systemic lupus erythematosus","volume":"69","author":"de Vries","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0660","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/annrheumdis-2012-201760","article-title":"HLA-DRB1*04\/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus","volume":"72","author":"Lundstrom","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0665","first-page":"ii56-61","article-title":"Recent insights into the genetic basis of systemic lupus erythematosus","volume":"72 Suppl 2","author":"Rullo","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0670","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/jhg.2011.49","article-title":"Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population","volume":"56","author":"Koga","year":"2011","journal-title":"J Hum Genet"},{"key":"10.1016\/j.autrev.2025.103756_bb0675","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2567.2002.01417.x","article-title":"The 52 000 MW Ro\/SS-A autoantigen in Sjogren's syndrome\/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures","volume":"106","author":"Rhodes","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2025.103756_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100138","article-title":"Autoantibodies in Sjogren's syndrome and its classification criteria","volume":"5","author":"Veenbergen","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.autrev.2025.103756_bb0685","article-title":"Autoantibody-associated psychiatric symptoms and syndromes in adults: a narrative review and proposed diagnostic approach","volume":"9","author":"Hansen","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.autrev.2025.103756_bb0690","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.1073\/pnas.112338099","article-title":"Cellular transcriptional profiling in influenza a virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza","volume":"99","author":"Geiss","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2025.103756_bb0695","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/606195","article-title":"Clinical and pathological roles of Ro\/SSA autoantibody system","volume":"2012","author":"Yoshimi","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0700","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages","volume":"179","author":"Kong","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0705","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2025.103756_bb0710","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-007-9157-0","article-title":"Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies","volume":"28","author":"Strandberg","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0715","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1212\/WNL.44.5.899","article-title":"Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjogren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates","volume":"44","author":"Alexander","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103756_bb0720","doi-asserted-by":"crossref","first-page":"9195157","DOI":"10.1155\/2023\/9195157","article-title":"Clinical significance of different profiles of anti-Ro antibodies in connective tissue diseases","volume":"2023","author":"Yang","year":"2023","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2025.103756_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103494","article-title":"Clinical significance of anti-SSA\/Ro antibody in Neuromyelitis optica spectrum disorders","volume":"58","author":"Lin","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103756_bb0730","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.tibs.2017.06.012","article-title":"D-Tyrosyl-tRNA Deacylase: a new function","volume":"42","author":"Calendar","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb0735","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature05096","article-title":"Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration","volume":"443","author":"Lee","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2025.103756_bb0740","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/ard-2023-224936","article-title":"Novel autoantibodies help diagnose anti-SSA antibody negative Sjogren disease and predict abnormal labial salivary gland pathology","volume":"83","author":"Parker","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0745","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022863","article-title":"Glutamatergic mechanisms associated with seizures and epilepsy","volume":"5","author":"Barker-Haliski","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010077","article-title":"NMDA and AMPA receptor autoantibodies in brain disorders: from molecular mechanisms to clinical features","volume":"10","author":"Gardoni","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2025.103756_bb0755","article-title":"The role of glutamate receptors in epilepsy","volume":"11","author":"Chen","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.autrev.2025.103756_bb0760","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/art.38852","article-title":"Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjogren's syndrome","volume":"66","author":"Lauvsnes","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0765","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410270313","article-title":"Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome","volume":"27","author":"Griffin","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb0770","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2025.103756_bb0775","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jnnp-2019-321849","article-title":"Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies","volume":"91","author":"Tholance","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2025.103756_bb0780","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/acn3.51053","article-title":"Immune-mediated axonal dysfunction in seropositive and seronegative primary Sjogren's syndrome","volume":"7","author":"Tani","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb0785","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-021-08865-2","article-title":"Autoantibodies in neuropsychiatric systemic lupus erythematosus (NPSLE): can they be used as biomarkers for the differential diagnosis of this disease?","volume":"63","author":"Manca","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0790","doi-asserted-by":"crossref","first-page":"1157149","DOI":"10.3389\/fimmu.2023.1157149","article-title":"Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"14","author":"Cocco","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102892","article-title":"Neuropsychiatric lupus erythematosus: focusing on autoantibodies","volume":"132","author":"Wang","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103756_bb0800","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2009.05.003","article-title":"Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus","volume":"212","author":"Colasanti","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2025.103756_bb0805","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/08820139.2019.1567534","article-title":"A Meta-analysis of cardiovascular events in systemic lupus erythematosus","volume":"48","author":"Gu","year":"2019","journal-title":"Immunol Invest"},{"key":"10.1016\/j.autrev.2025.103756_bb0810","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001247","article-title":"Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis","volume":"6","author":"Yazdany","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2025.103756_bb0815","series-title":"Seminars in arthritis and rheumatism","article-title":"Racial\/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus","author":"Barbhaiya","year":"2019"},{"key":"10.1016\/j.autrev.2025.103756_bb0820","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31138\/mjr.30.1.7","article-title":"Cerebrovascular events in systemic lupus erythematosus: diagnosis and management","volume":"30","author":"Nikolopoulos","year":"2019","journal-title":"Mediterr. J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0825","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/acr.23509","article-title":"Cerebrovascular events in systemic lupus erythematosus: results from an international inception cohort study","volume":"70","author":"Hanly","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2025.103756_bb0830","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/0961203320908947","article-title":"Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome","volume":"29","author":"Guraieb-Chahin","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb0835","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3899\/jrheum.200664","article-title":"Imaging pattern and outcome of stroke in patients with systemic lupus erythematosus: a case-control study","volume":"48","author":"Tsoi","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0840","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000168","article-title":"Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies","volume":"1","author":"Holmqvist","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2025.103756_bb0845","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/jmri.25966","article-title":"Intracranial vessel wall lesions in patients with systematic lupus erythematosus","volume":"48","author":"Ide","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.autrev.2025.103756_bb0850","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1002\/art.21475","article-title":"Precocious intima-media thickening in patients with primary Sjogren's syndrome","volume":"52","author":"Vaudo","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0855","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5152\/eurjrheum.2021.20093","article-title":"Primary Sjogren's syndrome as independent risk factor for subclinical atherosclerosis","volume":"9","author":"Novella-Navarro","year":"2022","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0860","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.3390\/jcm10215115","article-title":"Cardiovascular events, sleep Apnoea, and pulmonary hypertension in primary Sjogren\u2019s syndrome: data from the French health insurance database","volume":"10","author":"Goulabchand","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0865","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10067-014-2573-7","article-title":"Primary Sjogren's syndrome and risk of ischemic stroke: a nationwide study","volume":"33","author":"Chiang","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0870","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2377-12-41","article-title":"Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"12","author":"Zoller","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb0875","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/joim.12346","article-title":"Cardiovascular disease risk burden in primary Sjogren's syndrome: results of a population-based multicentre cohort study","volume":"278","author":"Bartoloni","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0880","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/acr.23821","article-title":"Cardiovascular morbidity and mortality in primary Sjogren\u2019s syndrome: a systematic review and Meta-analysis","volume":"72","author":"Beltai","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2025.103756_bb0885","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41584-024-01163-z","article-title":"Recent advances in the diagnosis and management of neuropsychiatric lupus","volume":"20","author":"Legge","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0890","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/art.24346","article-title":"Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study","volume":"61","author":"Appenzeller","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0895","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.3390\/cells11244054","article-title":"Cognitive performance in patients with systemic lupus erythematosus using the Ped-ANAM","volume":"11","author":"de Amorim","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2025.103756_bb0900","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/art.27404","article-title":"Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests","volume":"62","author":"Hanly","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196103","article-title":"Cognitive dysfunction improves in systemic lupus erythematosus: results of a 10 years prospective study","volume":"13","author":"Ceccarelli","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103756_bb0910","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/art.1780400825","article-title":"Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study","volume":"40","author":"Hanly","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0915","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0920","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard.2005.049486","article-title":"Hippocampal atrophy in systemic lupus erythematosus","volume":"65","author":"Appenzeller","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb0925","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.21271","article-title":"Cerebral and corpus callosum atrophy in systemic lupus erythematosus","volume":"52","author":"Appenzeller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb0930","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3899\/jrheum.111504","article-title":"Screening for cognitive impairment in systemic lupus erythematosus","volume":"39","author":"Hanly","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb0935","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/acr.24971","article-title":"Assessing the utility of the Montreal cognitive assessment in screening for cognitive impairment in patients with systemic lupus erythematosus","volume":"75","author":"Tayer-Shifman","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2025.103756_bb0940","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/acr.24096","article-title":"Validity evidence for the use of automated Neuropsychologic assessment metrics as a screening tool for cognitive impairment in systemic lupus erythematosus","volume":"72","author":"Tayer-Shifman","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2025.103756_bb0945","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/09612033211062530","article-title":"Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus","volume":"31","author":"Yuen","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb0950","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/09612033231168477","article-title":"In-person versus virtual administration of the American College of Rheumatology gold standard cognitive battery in systemic lupus erythematosus: are they interchangeable?","volume":"32","author":"Barraclough","year":"2023","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb0955","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/gps.3787","article-title":"Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment","volume":"28","author":"Memoria","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.autrev.2025.103756_bb0960","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/rheumatology\/keac343","article-title":"Resting state functional connectivity in SLE patients and association with cognitive impairment and blood-brain barrier permeability","volume":"62","author":"Hanly","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103756_bb0965","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000668","article-title":"Role of autoantibodies and blood-brain barrier leakage in cognitive impairment in systemic lupus erythematosus","volume":"9","author":"Hanly","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103756_bb0970","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1355617711000191","article-title":"Cognitive dysfunction and white matter abnormalities in systemic lupus erythematosus","volume":"17","author":"Kozora","year":"2011","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.autrev.2025.103756_bb0975","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.586","article-title":"Cognition, depression, fatigue, and quality of life in primary Sjogren's syndrome: correlations","volume":"6","author":"Kocer","year":"2016","journal-title":"Brain Behav"},{"key":"10.1016\/j.autrev.2025.103756_bb0980","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/501327","article-title":"Cognitive dysfunction and dementia in primary Sjogren\u2019s syndrome","volume":"2013","author":"Blanc","year":"2013","journal-title":"ISRN Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb0985","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-014-3097-9","article-title":"Frequent involvement of central nervous system in primary Sjogren syndrome","volume":"35","author":"Moreira","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2025.103756_bb0990","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006384","article-title":"Impact of pain on cognitive functions in primary Sjogren syndrome with small fiber neuropathy: 10 cases and a literature review","volume":"96","author":"Indart","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103756_bb0995","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0404.2009.01293.x","article-title":"Is there progressive cognitive dysfunction in Sjogren syndrome? A preliminary study","volume":"122","author":"Martinez","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2025.103756_bb1000","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-103-3-344","article-title":"Neuropsychiatric dysfunction in primary Sjogren's syndrome","volume":"103","author":"Malinow","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2025.103756_bb1005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1756-185X.12912","article-title":"Primary Sjogren's syndrome is associated with significant cognitive dysfunction","volume":"19","author":"Tezcan","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0404.2011.01530.x","article-title":"Primary Sjogren's syndrome: cognitive symptoms, mood, and cognitive performance","volume":"125","author":"Segal","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2025.103756_bb1015","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1002\/art.38127","article-title":"Memory dysfunction in primary Sjogren's syndrome is associated with anti-NR2 antibodies","volume":"65","author":"Lauvsnes","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb1020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.sult.2023.03.017","article-title":"The role of MRI in differentiating demyelinating and inflammatory (not infectious) myelopathies","volume":"44","author":"Tamanini","year":"2023","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.autrev.2025.103756_bb1025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/ard.2008.090811","article-title":"Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a case-control study","volume":"69","author":"Le Guern","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.410140410","article-title":"Polymorphous meningitis with atypical mononuclear cells in Sjogren's syndrome","volume":"14","author":"de la Monte","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1035","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1177\/0961203320961466","article-title":"Proton magnetic resonance spectroscopy ((1)H-MRS) in rheumatic autoimmune diseases: a systematic review","volume":"29","author":"Frittoli","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/hcr218","article-title":"White matter abnormalities in primary Sjogren syndrome","volume":"105","author":"Akasbi","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2025.103756_bb1045","series-title":"Seminars in Arthritis and Rheumatism","article-title":"Primary headache in SLE\u2013systematic review and meta-analysis","author":"Feld","year":"2024"},{"key":"10.1016\/j.autrev.2025.103756_bb1050","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/art.38106","article-title":"Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study","volume":"65","author":"Hanly","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb1055","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1468-2982.2004.00785.x","article-title":"Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage","volume":"24","author":"Appenzeller","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.autrev.2025.103756_bb1060","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/ene.12447","article-title":"High headache-related disability in patients with systemic lupus erythematosus and primary Sjogren's syndrome","volume":"21","author":"Tjensvoll","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1065","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2008.098301","article-title":"Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study","volume":"68","author":"Harboe","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.seizure.2021.02.021","article-title":"Seizures in systemic lupus erythematosus: a scoping review","volume":"86","author":"Rodriguez-Hernandez","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.autrev.2025.103756_bb1075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3899\/jrheum.150135","article-title":"Predictors of incident seizure in systemic lupus erythematosus","volume":"43","author":"Huang","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1080","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","article-title":"Epileptic seizures in systemic lupus erythematosus","volume":"63","author":"Appenzeller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103756_bb1085","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/annrheumdis-2011-201089","article-title":"Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study","volume":"71","author":"Hanly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1090","series-title":"Seminars in pediatric neurology","article-title":"Epilepsy in systemic autoimmune disorders","author":"Valencia","year":"2014"},{"key":"10.1016\/j.autrev.2025.103756_bb1095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1590\/S0004-282X2000000100007","article-title":"Magnetic resonance imaging in the evaluation of patients with aseptic meningoencephalitis and connective tissue disorders","volume":"58","author":"Appenzeller","year":"2000","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.autrev.2025.103756_bb1100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000186504","article-title":"Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus","volume":"61","author":"Baizabal-Carvallo","year":"2009","journal-title":"Eur Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1110","first-page":"595","article-title":"Aseptic meningitis as an initial presentation of Sjogren syndrome: a report of two cases and literature review","volume":"82","author":"Akiyama","year":"2020","journal-title":"Nagoya J Med Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb1115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1440-1789.2004.00542.x","article-title":"Nonvasculitic autoimmune inflammatory meningoencephalitis","volume":"24","author":"Josephs","year":"2004","journal-title":"Neuropathology"},{"key":"10.1016\/j.autrev.2025.103756_bb1120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.rbr.2015.12.006","article-title":"Myelopathy in systemic lupus erythematosus: clinical, laboratory, radiological and progression findings in a cohort of 1,193 patients","volume":"56","author":"Costallat","year":"2016","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"10.1016\/j.autrev.2025.103756_bb1125","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb1130","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00296-011-2053-1","article-title":"Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases","volume":"32","author":"Schulz","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2025.103756_bb1135","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/rheumatology\/keaa757","article-title":"Childhood Sjogren syndrome: features of an international cohort and application of the 2016 ACR\/EULAR classification criteria","volume":"60","author":"Basiaga","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103756_bb1140","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/1352458509106636","article-title":"Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica","volume":"15","author":"Kim","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2025.103756_bb1145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003495-200464020-00001","article-title":"Myelopathy in Sjogren's syndrome: role of nonsteroidal immunosuppressants","volume":"64","author":"Rogers","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.autrev.2025.103756_bb1150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.autrev.2009.04.005","article-title":"Acute transverse myelitis: a practical reappraisal","volume":"9","author":"Sa","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb1155","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1148\/rg.210045","article-title":"Central nervous system systemic lupus erythematosus: pathophysiologic, clinical, and imaging features","volume":"42","author":"Ota","year":"2022","journal-title":"Radiographics"},{"key":"10.1016\/j.autrev.2025.103756_bb1160","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.889613","article-title":"Demyelinating syndromes in systemic lupus erythematosus: data from the \u201cAttikon\u201d lupus cohort","volume":"13","author":"Nikolopoulos","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1165","doi-asserted-by":"crossref","first-page":"1128315","DOI":"10.3389\/fneur.2023.1128315","article-title":"CNS demyelinating events in primary Sjogren\u2019s syndrome: a single-center case series on the clinical phenotype","volume":"14","author":"Afzali","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.25146","article-title":"Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies","volume":"83","author":"Maggi","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/1531-8257(199903)14:2<262::AID-MDS1011>3.0.CO;2-6","article-title":"Parkinsonism associated with Sjogren's syndrome: three cases and a review of the literature","volume":"14","author":"Walker","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.autrev.2025.103756_bb1180","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000971","article-title":"Movement and other neurodegenerative syndromes in patients with systemic rheumatic diseases: a case series of 8 patients and review of the literature","volume":"94","author":"Menezes","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103756_bb1185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semarthrit.2013.05.002","article-title":"Neurologic involvement in scleroderma: a systematic review","volume":"43","author":"Amaral","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb1190","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0961203316643598","article-title":"Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus","volume":"25","author":"Ferreira","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1195","first-page":"133","article-title":"The spread of brain oedema in hypertensive brain injury","volume":"64","author":"Kalimo","year":"1986","journal-title":"Med Biol"},{"key":"10.1016\/j.autrev.2025.103756_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102739","article-title":"Posterior reversible encephalopathy syndrome: a neuropsychiatric manifestation of systemic lupus erythematosus","volume":"20","author":"Valdez-Lopez","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb1205","article-title":"The Association of Hypertension with Posterior Reversible Encephalopathy Syndrome in systemic lupus erythematosus patients: a systematic review","volume":"15","author":"Bhangu","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2025.103756_bb1210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5692\/clinicalneurol.cn-001809","article-title":"Atypical posterior reversible encephalopathy syndrome associated with Sjogren'\u200ds syndrome: a case report","volume":"63","author":"Kachi","year":"2023","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.autrev.2025.103756_bb1215","first-page":"2468","article-title":"Posterior reversible encephalopathy syndrome in a patient with anticentromere positive Sjogren's syndrome\/mixed connective tissue disease overlap: a case report and review of the literature","volume":"40","author":"Bellos","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.40764","article-title":"Psychosis in systemic lupus erythematosus: results from an international inception cohort study","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1225","series-title":"Seminars in arthritis and rheumatism","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","author":"Unterman","year":"2011"},{"key":"10.1016\/j.autrev.2025.103756_bb1230","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2147\/NDT.S97753","article-title":"One patient with Sjogren's syndrome presenting schizophrenia-like symptoms","volume":"12","author":"Lin","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.autrev.2025.103756_bb1235","doi-asserted-by":"crossref","first-page":"5520927","DOI":"10.1155\/2024\/5520927","article-title":"Exploring the psychiatric manifestations of primary Sjogren\u2019s syndrome: a narrative review","volume":"2024","author":"Salehi","year":"2024","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.22305","article-title":"Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study","volume":"56","author":"Hanly","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb1245","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3899\/jrheum.140111","article-title":"Predictors of incident depression in systemic lupus erythematosus","volume":"41","author":"Huang","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1250","first-page":"171","article-title":"Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus","volume":"17","author":"Perricone","year":"2015","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2025.103756_bb1255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0961203313513818","article-title":"Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report","volume":"23","author":"Bogaczewicz","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1260","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.autrev.2014.09.001","article-title":"The importance of cytokines and autoantibodies in depression","volume":"14","author":"Postal","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb1265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2017.05.059","article-title":"Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder","volume":"379","author":"Saito","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb1270","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/0961203317742711","article-title":"Suicidal ideation in systemic lupus erythematosus: NR2A gene polymorphism, clinical and psychosocial factors","volume":"27","author":"Buji","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0961203315603136","article-title":"Prevalence and correlates of suicidal thoughts in patients with neuropsychiatric lupus","volume":"25","author":"Hajduk","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1280","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2015.11.052","article-title":"Executive dysfunction, obsessive-compulsive symptoms, and attention deficit and hyperactivity disorder in systemic lupus erythematosus: evidence for basal ganglia dysfunction?","volume":"360","author":"Maciel","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb1285","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1177\/0961203315593817","article-title":"Symptoms of attention deficit hyperactivity disorder in patients with systemic lupus erythematosus","volume":"24","author":"Gao","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.41070","article-title":"Peripheral nervous system disease in systemic lupus erythematosus: results from an international inception cohort study","volume":"72","author":"Hanly","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1295","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.autrev.2017.05.011","article-title":"Peripheral nervous system involvement in systemic lupus erythematosus: prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single Centre","volume":"16","author":"Toledano","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb1300","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.38302","article-title":"Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period","volume":"66","author":"Oomatia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1305","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/jns.12644","article-title":"Clinical, histologic, and immunologic signatures of small Fiber neuropathy in systemic lupus erythematosus","volume":"29","author":"Galosi","year":"2024","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2025.103756_bb1310","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1055\/s-0043-1777105","article-title":"Sjogren's syndrome: a neurological perspective","volume":"81","author":"Barsottini","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.autrev.2025.103756_bb1315","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/873587","article-title":"Sensory Neuronopathy and autoimmune diseases","volume":"2012","author":"Martinez","year":"2012","journal-title":"Autoimmune Diseases"},{"key":"10.1016\/j.autrev.2025.103756_bb1320","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jon.12210","article-title":"Neuroimaging in sensory Neuronopathy","volume":"25","author":"Casseb","year":"2015","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.autrev.2025.103756_bb1325","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.autrev.2017.02.003","article-title":"Autoimmune neuropathies associated to rheumatic diseases","volume":"16","author":"Martinez","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb1330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ene.15555","article-title":"Primary Sjogren syndrome-related peripheral neuropathy: a systematic review and meta-analysis","volume":"30","author":"Liampas","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1335","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp.2010.222109","article-title":"Peripheral neuropathies in Sjogren syndrome: a new reappraisal","volume":"82","author":"Pavlakis","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2025.103756_bb1340","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.wnl.0000176034.38198.f9","article-title":"Painful small-fiber neuropathy in Sjogren syndrome","volume":"65","author":"Chai","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103756_bb1345","first-page":"889","article-title":"Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations","volume":"19","author":"Ferri","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1350","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001244","article-title":"Clinical features of Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuritis associated with SLE","volume":"11","author":"Wang","year":"2024","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103756_bb1355","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1016\/j.mjafi.2023.02.007","article-title":"Guillain-Barre syndrome as the initial presentation of systemic lupus erythematosus: case report with a systematic and literature review","volume":"79","author":"Bhoi","year":"2023","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.autrev.2025.103756_bb1360","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11481-023-10075-w","article-title":"Cyclophosphamide in the treatment of systemic lupus erythematosus-related Guillain-Barre syndrome: a systematic review of case reports","volume":"18","author":"Xiong","year":"2023","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.autrev.2025.103756_bb1365","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1038\/s41598-024-56365-y","article-title":"Clinical characteristics of Guillain-Barre syndrome in patients with primary Sjogren's syndrome","volume":"14","author":"Cao","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103756_bb1370","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2169\/internalmedicine.2226-23","article-title":"Subacute progressive severe ataxic sensory neuropathy with Sjogren\u2019s syndrome","volume":"63","author":"Fujioka","year":"2024","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2025.103756_bb1375","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1734-1140(10)70261-9","article-title":"Guillain-Barre syndrome (GBS)","volume":"62","author":"Pithadia","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.autrev.2025.103756_bb1380","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barre syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1385","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1390","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0961203308101546","article-title":"Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus","volume":"18","author":"Appenzeller","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1395","article-title":"Oculopharyngeal muscular dystrophy, myasthenia gravis, systemic lupus erythematosus: overlap and interactions","volume":"17","author":"Barbosa","year":"2024","journal-title":"BMJ Case Reports CP"},{"key":"10.1016\/j.autrev.2025.103756_bb1400","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.8554","article-title":"Primary Sjogren\u2019s syndrome presenting as ptosis and eyelid swelling: a case report","volume":"12","author":"Khan","year":"2024","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.autrev.2025.103756_bb1405","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s10067-022-06294-w","article-title":"Association of early-onset myasthenia gravis and primary Sj\u00f6gren\u2019s syndrome: a case-based narrative review","volume":"41","author":"Hartert","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1410","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/096120339700600505","article-title":"Autonomic nerve dysfunction in systemic lupus erythematosus: evidence for a mild involvement","volume":"6","author":"Altomonte","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1415","doi-asserted-by":"crossref","unstructured":"Shalimar et al. (2006) Autonomic dysfunction in systemic lupus erythematosus. Rheumatol Int 26, 837\u2013840. https:\/\/doi.org\/10.1007\/s00296-005-0093-0.","DOI":"10.1007\/s00296-005-0093-0"},{"key":"10.1016\/j.autrev.2025.103756_bb1420","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/B978-0-444-63432-0.00022-0","article-title":"Autoimmune autonomic disorders","volume":"133","author":"McKeon","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.autrev.2025.103756_bb1425","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/mrcr\/rxab027","article-title":"Intravenous cyclophosphamide treatment for systemic lupus erythematosus with severe autonomic disorders confirmed by head-up tilt table test: a case series","volume":"6","author":"Umeda","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.autrev.2025.103756_bb1430","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1136\/annrheumdis-2011-201009","article-title":"Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome","volume":"71","author":"Newton","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1435","first-page":"2385","article-title":"Autonomic cardiovascular neuropathy in Sjogren's syndrome. A controlled study","volume":"25","author":"Andonopoulos","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1440","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/rheumatology\/ken107","article-title":"Autonomic nervous symptoms in primary Sjogren's syndrome","volume":"47","author":"Mandl","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103756_bb1445","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.2007.077594","article-title":"Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)","volume":"67","author":"Andrade","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1450","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0961203316674820","article-title":"Advanced MRI techniques: biomarkers in neuropsychiatric lupus","volume":"26","author":"Sarbu","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1455","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1460","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0961203315622821","article-title":"Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-Centre study","volume":"25","author":"Fanouriakis","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103756_bb1465","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(03)00135-9","article-title":"Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study","volume":"115","author":"Mok","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2025.103756_bb1470","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/art.1780370907","article-title":"Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus","volume":"37","author":"Denburg","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103756_bb1475","series-title":"Seminars in Arthritis and Rheumatism","article-title":"Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: a systematic review","author":"Papachristos","year":"2021"},{"key":"10.1016\/j.autrev.2025.103756_bb1480","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1093\/rheumatology\/keae119","article-title":"Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective study","volume":"63","author":"Bortoluzzi","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103756_bb1485","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/rheumatology\/kead249","article-title":"Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab","volume":"63","author":"Palazzo","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103756_bb1490","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1495","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.autrev.2018.04.009","article-title":"Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis","volume":"17","author":"Dufrost","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103756_bb1500","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103756_bb1505","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","article-title":"A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)","volume":"3","author":"Finazzi","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2025.103756_bb1510","first-page":"15","article-title":"Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome","volume":"7","author":"Okuma","year":"2009","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb1515","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0002-9343(92)90788-D","article-title":"Optic neuropathy and central nervous system disease associated with primary Sjogren's syndrome","volume":"92","author":"Tesar","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2025.103756_bb1520","first-page":"208","article-title":"Rituximab in central nervous system manifestations of patients with primary Sjogren's syndrome: results from the AIR registry","volume":"30","author":"Mekinian","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1525","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","article-title":"Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome","volume":"19","author":"Wakasugi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1530","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2008.12.018","article-title":"Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome","volume":"279","author":"Morozumi","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103756_bb1535","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2011-200086","article-title":"Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry","volume":"71","author":"Mekinian","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103756_bb1540","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003632","article-title":"Sjogren sensory Neuronopathy (Sjogren Ganglionopathy): long-term outcome and treatment response in a series of 13 cases","volume":"95","author":"Pereira","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103756_bb1545","first-page":"1552","article-title":"Pure sensory neuropathy in primary Sjogren's syndrome. Longterm prospective followup and review of the literature","volume":"30","author":"Font","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103756_bb1550","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/01.WNL.0000046680.47883.7D","article-title":"Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren's syndrome. IV immunoglobulin","volume":"60","author":"Takahashi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103756_bb1555","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/acr.20495","article-title":"Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjogren's syndrome: a national multicentric retrospective study","volume":"63","author":"Rist","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T13:38:06Z","timestamp":1740922686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":311,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1568997225000163"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103756","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103756"}}